Sonoma Pharmaceuticals (SNOA) Enterprise Value (2010 - 2025)

Sonoma Pharmaceuticals' Enterprise Value history runs 16 years deep, the most recent figure standing at -$2.6 million for Q4 2025.

• In Q4 2025, Enterprise Value rose 51.09% year-over-year to -$2.6 million; the TTM figure through Dec 2025 stood at -$2.6 million (up 51.09% YoY), while the FY2025 annual figure was -$5.4 million, down 71.8% from the prior year.
• Enterprise Value was -$2.6 million for Q4 2025 at Sonoma Pharmaceuticals, up from -$3.0 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$2.1 million in Q3 2023 to a low of -$8.5 million in Q4 2021.
• Historically, Enterprise Value has averaged -$4.2 million across 5 years, with a median of -$3.6 million in 2023.
• The sharpest annual moves came in 2022 and 2024: Enterprise Value soared 69.12% in 2022, then sank 117.62% in 2024.
• A 5-year view of Enterprise Value shows it stood at -$8.5 million in 2021, then jumped by 69.12% to -$2.6 million in 2022, then rose by 8.66% to -$2.4 million in 2023, then plunged by 117.62% to -$5.2 million in 2024, then surged by 51.09% to -$2.6 million in 2025.
• The last three Enterprise Value figures came in at -$2.6 million (Q4 2025), -$3.0 million (Q3 2025), and -$3.6 million (Q2 2025), per Business Quant data.